Navigation Links
Oncologists Overlook Clot Risk

Cancer patients who receive treatment have a greater risk of developing blood clots, but a new study shows many doctors are not taking the necessary steps to prevent the clots from forming.//

Researchers in England, surveyed more than 100 oncologists to determine if the doctors were aware of the risk of blood clots and to evaluate preventative measures used by the physicians. About 40 percent of the doctors who were surveyed treated their patients with either chemotherapy or radiotherapy, and less than 10 percent said they used hormone therapy on their patients.

Results of the study show more than 90 of the 160 doctors surveyed thought radiotherapy posed little or no increased risk for blood clots. More than 80 doctors thought the same for chemotherapy, and more than 70 agreed hormone therapy did not increase the risk.

Of the doctors surveyed, 84 did not routinely recommend blood thinners, such as aspirin or warfarin, as a preventative measure for patients treated with chemotherapy. Seventy-nine doctors did not recommend the medication for hormone therapy patients, and 86 did not advise radiotherapy patients to use the blood thinners. Nearly 40 percent of the oncologists said less than 1 percent of their patients were currently using prophylactic measures for preventing blood clots.

Researchers say health care professionals need to be better educated about the potential increased risk of blood clots in cancer patients.

Thus researchers conclude, “National guidelines on prophylaxis for venous thromboembolism during cancer treatment are needed.”


Page: 1

Related medicine news :

1. Dental Health, a Much Overlooked Subject
2. Was the Warning of a Severe Reaction To a Drug, Overlooked?
Post Your Comments:

(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology: